Genome biologyBioinformaticsPeer-reviewed journal article
Gene-level metagenomics identifies genome islands associated with immunotherapy response
Samuel S. MinotiD, Kevin C. BarryiD, Caroline Kasman, Jonathan L. GolobiD, Amy D. WillisiD
Abstract
Researchers must be able to generate experimentally testable hypotheses from sequencing-based observational microbiome experiments to discover the mechanisms underlying the influence of gut microbes on human health. We describe a novel bioinformatics tool for identifying testable hypotheses based on gene-level metagenomic analysis of WGS microbiome data (geneshot). By applying geneshot to two independent previously published cohorts, we identified microbial genomic islands consistently associated with response to immune checkpoint inhibitor (ICI)-based cancer treatment in culturable type strains. The identified genomic islands are within operons involved in type II secretion, TonB-dependent transport, and bacteriophage growth. These results, as well as the underlying methodology, inform further mechanistic studies and facilitate the development of microbiome-enhanced therapeutics.
- organism: human
- assay: metagenomics
- research focus: gene regulatory network inference
- research focus: benchmarking
- research focus: database / resource
- approach: statistical model
- Citations
- 21
- FWCI
- 1.41
- Field percentile
- top 19%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mega- and meta-analyses of fecal metagenomic studies assessing response to immune checkpoint inhibitors
A. A. HEIRALI, B. Chen, … B. A. Coburn·bioRxiv·Apr 27, 2021
- Ecological and functional stratification of the stool microbiome predicts response to immune checkpoint inhibitors across cancer types
Vera Orletskaia, Evgenii I. Olekhnovich·Computational and Structural Biotechnology JournalPeer-reviewed·Mar 1, 2026
- Meta-analytic microbiome target discovery for immune checkpoint inhibitor response in advanced melanoma
Xinyang Zhang, Himel Mallick, Ali Rahnavard·Communications MedicinePeer-reviewed·May 21, 2026
- Taxonomy-free fecal microbiome profiles enable robust prediction of immunotherapy response and toxicity in melanoma
Anastasia Lucas, McKenna Reale, … Noam Auslander·bioRxiv·Nov 6, 2025
- The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors
C. E. Wheeler, , S. S. Coleman, … A. C. Tan·bioRxiv·May 24, 2023
- Reproducible stool metagenomic biomarkers linked to the melanoma immunotherapy positive outcome
Evgenii I. Olekhnovich, Artem B. Ivanov, … Elena Nikolaevna Ilina·bioRxiv·Apr 1, 2022